Interdisciplinary approaches to diagnosis and treatment of childhood diseases

 Dates: February 27-28, 2014

 

Venue: Bratislava hotel, hall  ”FORUM”, Ukraine, Kiev,Malishka str.1

More about event facility “FORUM” hall: http://www.bratislava.com.ua/spip.php?article43

Bratislava hotel website

Event facility “FORUM” hall  photo:

Tel:+380 44 2332770,  web-site: http://www.bratislava.com.ua/   e-mail: ukraine@nbscience.com

The hotel complex “Bratislava”, since 1989 known for the traditions of hospitality, is located on the left coast Dnepr in capital of Ukraine, near to underground stations “Darnica”. Near to hotel there is park ” Victory “, large trading complex « the Children’s world », International exhibition center

 Map of Bratislava hotel:

Bratislava hotel

Online registration is required.

No admission without registration confirmation.

nbscience

(deadline – January 12, 2014)

 

 Main topics:

This meeting has been consistently rated one of the top meetings in pediatrics.
In 2014, our distinguished faculty will continue to provide
attendees with features they value most, in addition to developing new
clinically relevant topics that will help enhance your practice

Programme:

7:00 am Registration and Continental Breakfast

7:45 Welcome and Opening Remarks

SESSION 1: Neonatal Lung Disease and Pulmonary Vascular Alterations
8:00 Systemic Vascular Changes Following Neonatal
Hyperoxia Exposure
8:30 Intracellular Signaling in the Development of BPD
9:00 Pulmonary Vascular Consequences of BPD
9:30 Long-term Consequences of BPD
10:00 Break

SESSION 2: Pulmonary Vascular Disease: Advanced Nursing Perspectives
10:30 Building a Successful Pediatric PH Program
11:00 Practical Aspects of Invasive Therapies
11:30 Successful Transition of the Late Adolescent
PH Patient: US vs. Canada/Europe Transition
Programs
12:00 Trisomy 21: Care for the Patient and Family
12:30 Lunch

 

1:30 Pediatric Pulmonary Vascular Disease:
Where We Were and Where We are Going
SESSION 3: Pulmonary Vasculature in Single Ventricular Physiology
2:30 Histological Features of the Pulmonary Vascular
Bed after the Fontan Operation
3:00 Pitfalls in PVR Determinations in SV Physiology
3:30 Break

3:45 Ventricular-Pulmonary Vascular Coupling
after the Total Cavopulmonary Anastomosis
4:15 Pulmonary A-V Malformations:
Diagnosis and Etiology
4:45 AHA-ATS Guidelines
5:15 The Sildenafil Controversy
5:45 PPHnet Update
 Day 2 

7:15 am Continental Breakfast

SESSION 4: Current Treatments for Pulmonary Vascular Disease
8:00 Inhalational Therapies
8:30 Intravenous Therapies
9:00 Oral Therapies
9:30 Subcutaneous Therapy
10:00 Break

10:30 When to Evaluate and List Children with
Pulmonary Hypertensive Vascular Disease for
Lung Transplantation
11:00 Mechanical Support of the Right Ventricle
in Children with Pulmonary Hypertensive
Vascular Disease
11:30 Assessing Therapies in Rare Diseases
12:00 Pediatric Formulations, Pharmaceutical
Excipients, and Drug Delivery Devices
12:30 pm Lunch

SESSION 5: CONCURRENT SESSIONS

1:30 – 2:45 5A: Original Research – Abstracts, Posters, and Presentations

5B: Family Session – Special Issues Faced By Families
Living with Pulmonary Hypertension
SESSION 6: Assessment of the Pulmonary Vasculature
2:45 Integration of Cardiac Catheterization
and MRI for Diagnosis, Reactivity Testing and
Disease Progression in Children with PVD
3:15 Echocardiographic Assessment of
RV Dysfunction in Children with PHVD
3:45 Break

4:00 Non-invasive Risk Predictors in Children with PH
4:30 The Pulmonary Vasculature and Assessment of
SESSION 7: Future Therapies
5:00 Rationale for Therapeutic PPARgamma activation in Pulmonary Vascular Disease
5:30 Stem Cells in Neonatal PH
6:00 Current Status of Stem Cell Therapy in Pulmonary Hypertensive Vascular Disease
7:00 pm Closing Remarks



Call for Poster Abstracts: 

Important dates:

Abstract submission deadline: February 01, 2014

Acceptance notification: February 09, 2014

The Scientific Program Committee invites you to submit your research in the form of a one-page abstract (2500 characters) . We welcome scholarly research-based submissions .  Case study abstracts will also be welcomed.

Abstracts should include unpublished material and data. Material that has been formally published by the abstract submission dates will not be accepted. Most abstracts without data to support findings will be rejected. However, abstracts that describe study design and methods for well-developed and/or funded studies (i.e., no abstracts for pilot or preliminary studies) may be considered for poster presentation depending on abstract quality.

All abstracts will be anonymously peer reviewed, scored and chosen on merit for poster presentation.

Individuals whose abstract are selected will be required to register for the meeting; abstracts from authors who do not register will not be accepted.


 Conditions of participation for participants:

Registration Package   includes  simultaneous translation from Russian to English language , certificate of participation (English language) ,participation in scientific sessions, conference materialsvisit to the exhibition and 10-30% discount for accomodation in hotel.

 

nbscience

(deadline – January 12, 2014)

 

 

Flights:

tickets ukraine

From Europe to Russia from 50 Euros ( one way) : http://wizzair.com/?language=EN

Questions

Contact NBScience’s

Education/Conference Department:

Tel: +38 (063) 277- 64- 65

conference@nbscience.com

pharmacology

AllConferences.com Directory of Conferences, conventions, exhibits, seminars, workshops, events, trade shows and business meetings. Includes calendar, dates, location, web site, contact and registration information.

stem cell therapy